• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Finance

Pendulum Therapeutics Raises $54 Million to Meet Surging Customer Demand

April 8, 2021 Microbiome Times

Pendulum Therapeutics – a biotech company improving health through products targeting the microbiome – today announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and […]

Pharma & Human Health

Fungi are present in your lungs

April 7, 2021 Microbiome Times

The lungs were for a long time considered to be sterile in health, while in diseases like chronic obstructive pulmonary disease (COPD) failure in immune mechanisms were thought to allow microorganisms to proliferate and persist. […]

Pharma & Human Health

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

April 6, 2021 Microbiome Times

MyBiotics Pharma Ltd., a microbiome therapeutics company, and Hadasit Medical Research Services and Development Ltd., the technology transfer office of Hadassah Medical Center, announced today that they have entered into a research collaboration and licensing agreement […]

Animal Health

Corals may need their predators’ poop

April 5, 2021 Microbiome Times

Fish that dine on corals may pay it forward with poop. It’s an unexpected twist on coral reef symbiosis, said Rice University marine biologist Adrienne Correa, whose lab discovered coral predator feces are jam-packed with […]

Finance

Probi and Sinopharm enter strategic partnership in China

March 29, 2021 Microbiome Times

Sinopharm will launch three probiotic supplements within the immune health, bone health and iron absorption areas based on Probi’s scientifically proven probiotic strains. Zhang Jian Ge, Director Pharmaceutical & Chemical Division of Sinopharm, states: “Sinopharm […]

Pharma & Human Health

New clinical study aims to prevent type 1 diabetes in children

March 28, 2021 Microbiome Times

SINT1A is led by Helmholtz Zentrum Muenchen, and part of the international GPPAD initiative including Prof. Ezio Bonifacio and his team at the Center for Regenerative Therapies Dresden at TU Dresden. Around one in 300 […]

Pharma & Human Health

Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors

March 26, 2021 Microbiome Times

ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health, today announces that it has received Investigational New Drug […]

Finance

4D Pharma Announces Completion of Merger with Longevity Acquisition Corporation and admission of ADS to trading on NASDAQ

March 22, 2021 Microbiome Times

4D pharma plc (AIM: DDDD) (“4D” or the “Company”), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, is pleased to announce that its […]

Finance

Sandwalk and General Inception announce their collaboration to develop next-generation microbiome technologies

March 18, 2021 Microbiome Times

Sandwalk BioVentures, the strategy firm specialized on microbiome technologies, has announced its collaboration with General Inception, a US-based venture studio focused on co-founding and building science-based companies from concept on. Sandwalk will lead the Microbiome […]

Phytobiome & Environment

Are ‘bacterial probiotics’ a game-changer for the biofuels industry?

March 18, 2021 Microbiome Times

In a study recently published in Nature Communications, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU) and Yale University have investigated how bacteria that are commonly found in sugarcane ethanol fermentation affect the […]

Finance

Microba Life Sciences partners with Unilever to target sleep through the gut microbiome

March 17, 2021 Microbiome Times

The Centre for Disease Control and Prevention (CDC) has declared insufficient sleep a ‘public health problem’, with more than one-third of American adults not getting enough sleep on a regular basis. Experts in gut microbiome […]

Posts navigation

« 1 … 33 34 35 … 78 »

Download the MT Forum Agenda:

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
sign up

Sign up to the Microbiome Times newsletter